donepezil hydrochloride (Aricept)

ApprovedCompleted

0 watching 0 views this week🔥 Hot

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Vascular Dementia

Conditions

Vascular Dementia

Trial Timeline

Sep 1, 2005 → —

NCT ID

NCT00165763

About donepezil hydrochloride (Aricept)

donepezil hydrochloride (Aricept) is a approved stage product being developed by Eisai for Vascular Dementia. The current trial status is completed. This product is registered under clinical trial identifier NCT00165763. Target conditions include Vascular Dementia.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (3)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00675025	Phase 2	Terminated	Apr 4, 2008	Dec 15, 2008	Down Syndrome
NCT00711204	Approved	Withdrawn	Jan 1, 2008	—	Severe Alzheimer's Disease
NCT00165763	Approved	Completed	Sep 1, 2005	—	Vascular Dementia

Competing Products

20 competing products in Vascular Dementia

See all competitors

Product	Company	Stage	Hype Score
CLS-AX + Anti-VEGF	Clearside Biomedical	Phase 1/2	33
CLS-AX + Aflibercept	Clearside Biomedical	Phase 2	44
Eylea + ALT-L9	Alteogen	Phase 1	33
Dulaglutide + Placebo	Eli Lilly	Phase 3	77
raloxifene + placebo	Eli Lilly	Phase 3	77
Evacetrapib	Eli Lilly	Phase 1	33
Orforglipron + Placebo	Eli Lilly	Phase 3	77
UBX1325 injection 50 μL + EYLEA® (aflibercept) Injection 2 mg (0.05mL)	Unity Biotechnology	Phase 2	44
Prasugrel (CS-747) + Clopidogrel	Eli Lilly	Phase 2	52
Rosuvamibe + Monorova	Yuhan	Approved	85
Efficacy and safety of combination therapy of moderate-intensity statin and ezetimibe compared to high-intensity statin	Yuhan	Approved	85
Rosuvamibe + Monorova	Yuhan	Approved	85
olmesartan	Daiichi Sankyo	Pre-clinical	23
DS-7080a + Ranibizumab	Daiichi Sankyo	Phase 1	33
Prasugrel (Crushed tablets) + Prasugrel (Integral tablets)	Daiichi Sankyo	Approved	85
Avacincaptad Pegol	Astellas Pharma	Phase 1	33
Avacincaptad Pegol + Avastin + Lucentis + Eylea	Astellas Pharma	Phase 2	52
Lexiscan	Astellas Pharma	Phase 2	52
YM872 (zonampanel)	Astellas Pharma	Phase 2	52
Avacincaptad Pegol + Lucentis	Astellas Pharma	Phase 2	52

Other Products from Eisai

MecobalaminApproved

MonteplaseApproved

E2020 + PlaceboApproved

Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved

DonepezilApproved